Edgewise announces completion of EDG-7500 CIRRUS-HCM phase 2 parts B & C and favourable interim safety results from the ongoing part D study in hypertrophic cardiomyopathy ...
Avantor trades at multi-year lows amid earnings contraction, with low margins, declining operations, and limited near-term catalysts for upside. AVTR's Q2 showed flat organic growth, mid-teens ...
Revision of DaVita to Hold, as incremental capital investments have failed to create market value, signaling subpar returns and economic value destruction. Despite strong cash flow and margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback